MedTrace Logo

nSeP: Detecting Neonatal Sepsis by Immune-Metabolic Network Analysis

NCT03777670 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-04-07

No results posted yet for this study

Summary

Diagnosis of neonatal sepsis remains a challenge due to non-specific signs and diagnostic inaccuracies. Studies have shown that this could lead to overdiagnosis and overuse of antibiotic treatment, with potential long-term adverse effects.

A systems approach towards diagnosing neonatal sepsis has been shown to have high accuracy in initial studies. This study aims to recruit a large validation cohort to confirm findings.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood test

Drop of blood for RNA and metabolic analysis

Sponsors & Collaborators

  • Cardiff University

    collaborator OTHER

  • Cardiff and Vale University Health Board

    lead OTHER_GOV

Eligibility

Max Age
4 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-26
Primary Completion
2023-02-28
Completion
2024-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03777670 on ClinicalTrials.gov